MICHAEL LELAND: Open Payments
NPI 1356896955 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,718 in 141 payments from 21 companies in 2025. Trend: 2023 $2,040 · 2024 $1,854 · 2025 $2,718
Food & beverage: $2,632Education: $86
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $409 |
| AstraZeneca Pharmaceuticals LP | 19 | $359 |
| LEO Pharma Inc. | 14 | $325 |
| GENZYME CORPORATION | 10 | $266 |
| ABBVIE INC. | 10 | $186 |
| Regeneron Healthcare Solutions, Inc. | 10 | $179 |
| ARS Pharmaceuticals Operations, Inc. | 15 | $172 |
| Amgen Inc. | 12 | $136 |
| Incyte Corporation | 6 | $130 |
| GlaxoSmithKline, LLC. | 6 | $116 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NEFFY, ADBRY, ANZUPGO, OPZELURA, Xolair.
Industry payments across TN — which companies pay providers there.
